Terumo Corp (4543 JP): H1FY23 Results Reflect Continued Recovery from the Pandemic
Terumo is on a strong double-digit revenue growth path due to continued COVID-related recovery of the procedure volume globally. The company should...
488 Views
Global Medtech Trends: Readouts from Early Birds of Q3 Earnings Season- Positives and Negatives
Q3 results of large U.S. medtech companies recorded procedure volume growth. However, macroeconomic headwinds are expected to prevail. Similar...
258 Views
Asahi Intecc (7747 JP): Recovery From COVID-19 to Drive Double-Digit Revenue Growth in Near-Term
Asahi Intecc is well-positioned for a revenue CAGR of 12% during FY21–26, driven by recovery from the impact of COVID, market share gain of...
460 Views
Olympus (7733 JP) Q4FY22: Net Profit More Than Doubled; Record High Profit Projection for FY23
Olympus reported strong 0FY22 performance, ahead of its guidance. FY23 guidance is better than expectations, with net profit expected to reach a...
389 Views
PHC Holdings IPO - Should Have Cut the Price, Not Just the Size
PHC Holdings and its shareholders aim to raise around US$700m, down from US$1.8bn, via selling a mix of primary and secondary shares in its Japan IPO.
411 Views